JVMSX | SVYAX | JVMSX / SVYAX | |
Total Expense Ratio | 1.25 | 0.20 | 625% |
Annual Report Gross Expense Ratio | 1.26 | 0.62 | 203% |
Fund Existence | 13 years | 17 years | - |
Gain YTD | 8.728 | 8.738 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.6B | 291M | 8,110% |
Annual Yield % from dividends | 0.41 | 2.60 | 16% |
Returns for 1 year | 0.34 | 2.35 | 15% |
Returns for 3 years | 10.96 | -3.17 | -345% |
Returns for 5 years | 48.09 | 3.82 | 1,259% |
Returns for 10 years | 41.60 | 0.91 | 4,550% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBIOX | 20.45 | 0.19 | +0.94% |
Fidelity Select Biotechnology | |||
AEPCX | 59.68 | 0.35 | +0.59% |
American Funds EUPAC C | |||
ABWCX | 16.11 | -0.03 | -0.19% |
AB All Market Total Return C | |||
MREFX | 15.63 | -0.04 | -0.26% |
BlackRock International Select Eq R | |||
ABCRX | 23.71 | -0.12 | -0.50% |
American Beacon The London Co Inc Eq R6 |